Monday, December 31, 2018

Lupin gets USFDA nod for Clobazam Oral Suspension

Lupin gets USFDA nod for Clobazam Oral Suspension The drug is indicated for treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in patients of two years of age or older.

from Moneycontrol Business News http://bit.ly/2SzDNZX

No comments:

Post a Comment

Zaynich's blockbuster potential lifts Wockhardt's long-term outlook

Wockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years o...